首页> 外文期刊>Therapeutic advances in gastroenterology. >Endoscopic management of complications of self-expandable metal stents for treatment of malignant esophageal stenosis and tracheoesophageal fistulas
【24h】

Endoscopic management of complications of self-expandable metal stents for treatment of malignant esophageal stenosis and tracheoesophageal fistulas

机译:内镜治疗自扩张金属支架治疗食管恶性狭窄和气管食管瘘的并发症

获取原文
           

摘要

Self-expandable metal stent (SEMS) implantation may rapidly improve the symptoms of malignant esophageal stenosis and tracheoesophageal fistulas (TEF). However, dysphagia often returns subsequently and repeated endoscopic intervention may be necessary. The aims of the study were to identify the risk factors of complications, and the frequency and efficacy of repeated endoscopic interventions; and to provide technical recommendations on appropriate stent selection. We analyzed retrospectively the clinical data of 212 patients with locally advanced esophageal cancer who underwent SEMS implantation. A total of 238 SEMS implantations were performed with 99.06% technical success and 1.26% procedure-related deaths in the enrolled 212 cases. Complications occurred in 84 patients (39.62%) and in 55 cases (25.94%) repeated endoscopic procedures were required. Early reintervention 24–48 h after the stent implantations was necessary due to stent migration (12 cases), arrhythmia (2 cases), intolerable retrosternal pain (1 case) and dyspnea (1 case). An average of 1.98 repeated gastroscopies (range 1–6; median 2), 13.58 weeks (range 1.5–48; median 11) after the stent implantation were performed during the follow-up period: 37 stent repositions, 23 restent implantations, 15 endoscopic esophageal dilations and 7 stent removals. In 48 cases (87.3%) oral feeding of patients was made possible by endoscopic interventions. In a quarter of SEMS implantations, complications occur that can be successfully managed by endoscopic interventions. Our experiences have shown that individualized stent choice may substantially reduce the complications rate and make repeated endoscopic interventions easier.
机译:自膨胀金属支架(SEMS)植入可以迅速改善恶性食管狭窄和气管食管瘘(TEF)的症状。但是,吞咽困难通常会随后复发,因此可能需要反复进行内镜干预。该研究的目的是确定并发症的危险因素,以及重复内镜干预的频率和功效。并提供有关适当支架选择的技术建议。我们回顾性分析了212例接受SEMS植入的局部晚期食管癌患者的临床资料。纳入的212例患者共进行了238例SEMS植入,技术成功率为99.06%,手术相关死亡为1.26%。 84例(39.62%)发生并发症,而55例(25.94%)则需要重复内窥镜检查。由于支架迁移(12例),心律不齐(2例),无法忍受的胸骨后疼痛(1例)和呼吸困难(1例),必须在支架植入后24-48 h进行早期再干预。在随访期间平均进行了1.98次重复胃镜检查(范围1–6;中位2),13.58周(范围1.5–48;中位11),随访时间:支架置入37次,支架置入23次,内窥镜检查15次食道扩张和7个支架切除术。在48例(87.3%)的患者中,通过内窥镜干预可以使患者口服。在SEMS植入的四分之一中,会发生并发症,这些并发症可以通过内窥镜干预得以成功处理。我们的经验表明,个性化支架的选择可以显着降低并发症发生率,并使重复内镜治疗变得更加容易。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号